BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 6430053)

  • 1. Antianginal effects of nitroglycerin patches.
    Reichek N; Priest C; Zimrin D; Chandler T; Sutton MS
    Am J Cardiol; 1984 Jul; 54(1):1-7. PubMed ID: 6430053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antianginal effects of intravenous nitroglycerin over 24 hours.
    Zimrin D; Reichek N; Bogin KT; Aurigemma G; Douglas P; Berko B; Fung HL
    Circulation; 1988 Jun; 77(6):1376-84. PubMed ID: 3131041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Sustained effect of nitroglycerin ointment on exercise tolerance in patients with effort angina (author's transl)].
    Previtali M; Salerno JA; Falcone C; Lepore R; Chimienti M; Medici A; Angoli L; Bobba P
    G Ital Cardiol; 1980; 10(5):584-91. PubMed ID: 6778754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ointments and transdermal nitroglycerin patches for stable angina pectoris.
    Thadani U; Lipicky RJ
    Cardiovasc Drugs Ther; 1994 Aug; 8(4):625-33. PubMed ID: 7848897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-ischaemic response to sublingual nitroglycerin during oral administration of isosorbide dinitrate in patients with stable angina pectoris: when does cross-tolerance occur?
    Kośmicki MA; Szwed H; Sadowski Z
    Cardiovasc Drugs Ther; 2004 Jan; 18(1):47-55. PubMed ID: 15115903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitrate cross-tolerance: effect of sublingual isosorbide dinitrate and nitroglycerin during sustained nitrate therapy.
    Dalal JJ; Parker JO
    Am J Cardiol; 1984 Aug; 54(3):286-8. PubMed ID: 6431795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-acting nitrates: relative utility of nitroglycerin patches.
    Reichek N
    Am J Med; 1984 Jun; 76(6A):63-6. PubMed ID: 6430079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute and chronic antianginal efficacy of continuous twenty-four-hour application of transdermal nitroglycerin. Steering Committee, Transdermal Nitroglycerin Cooperative Study.
    Am J Cardiol; 1991 Nov; 68(13):1263-73. PubMed ID: 1951111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of the day-long antianginal effectiveness of nitroglycerin patches with that of three-times-daily isosorbide dinitrate: a double-blind study using dose titration.
    Bassan MM; Rogel S
    Eur Heart J; 1992 Sep; 13(9):1265-70. PubMed ID: 1396839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of a transdermal patch system containing nitroglycerin on exercise tolerance in patients with angina pectoris. Double-blind, placebo controlled, comparison with slow-release nifedipine and verapamil.
    Gibelli G; Negrini M; Mazzocchi F; Prina L; Pollavini P; De Ponti C
    G Ital Cardiol; 1986 Nov; 16(11):904-8. PubMed ID: 3104124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of intermittent transdermal nitroglycerin on occurrence of ischemia after patch removal: results of the second transdermal intermittent dosing evaluation study (TIDES-II).
    Pepine CJ; Lopez LM; Bell DM; Handberg-Thurmond EM; Marks RG; McGorray S
    J Am Coll Cardiol; 1997 Oct; 30(4):955-61. PubMed ID: 9316524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transdermal nitroglycerin patches in angina pectoris. Dose titration, duration of effect, and rapid tolerance.
    Thadani U; Hamilton SF; Olson E; Anderson J; Voyles W; Prasad R; Teague SM
    Ann Intern Med; 1986 Oct; 105(4):485-92. PubMed ID: 3092711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects on exercise tolerance of a new transdermal therapeutic system containing nitroglycerine, in patients with stable angina pectoris.
    Carù B; Pirelli S; Ferratini M; Gasparini M; Cattafi G; Corrada E; Pollavini P
    Eur Heart J; 1988 Jan; 9 Suppl A():105-11. PubMed ID: 3137062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitroglycerin ointment effective for seven hours in severe angina pectoris.
    Kala R; Hirvonen P; Gordin A; Sundberg S; Auvinen J; Halonen PI
    Acta Med Scand; 1983; 213(3):165-70. PubMed ID: 6405584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. When does nitrate tolerance develop? What dosages and which intervals are necessary to ensure maintained effectiveness?
    Rudolph W; Dirschinger J; Reiniger G; Beyerle A; Hall D
    Eur Heart J; 1988 Jan; 9 Suppl A():63-72. PubMed ID: 3137072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transdermal nitroglycerin in angina pectoris.
    Parker JO; Fung HL
    Am J Cardiol; 1984 Sep; 54(6):471-6. PubMed ID: 6433687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of a new transdermal nitroglycerin patch (Deponit 10) for stable angina pectoris.
    Greco R; D'Alterio D; Schiattarella M; Boccia A; Greco L; Marsico F
    Am J Cardiol; 1988 Mar; 61(9):44E-51E. PubMed ID: 3126635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of nitroglycerin in effort angina.
    Reichek N
    Am J Med; 1983 Jun; 74(6B):33-9. PubMed ID: 6134467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of a new transdermal therapeutic system containing nitroglycerin on exercise capacity in patients with angina pectoris.
    Scardi S; Pivotti F; Fonda F; Pandullo C; Castelli M; Pollavini G
    Am Heart J; 1985 Sep; 110(3):546-51. PubMed ID: 3929579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The day-long antianginal effectiveness of nitroglycerin patches. A double-blind study using dose-titration.
    Bassan M
    Chest; 1991 May; 99(5):1120-5. PubMed ID: 1902159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.